cnbc semaglutide FDA approves first GLP-1 pill for obesity from Wegovy maker Novo Nordisk My segment on @SquawkCNBC today

What to Expect: More stable energy throughout the day Improved exercise performance and recovery Better stress tolerance Still minimal weight changes Research Context: Studies show NNMT inhibition improves cellular energy expenditure within 2-4 weeks

Injections are more likely to cause injection-site reactions such as redness, itching, or mild swelling

Pain perception is individual, but the front of the thigh has somewhat fewer nerve endings per square centimeter than the periumbilical area of the abdomen

Cureus 1(9):117 Helmstdter J, Keppeler K, Kster L, Mnzel T, Daiber A, Steven S (2022) Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefitsthe role of the GLP-1 receptor